tradingkey.logo
tradingkey.logo
Search

Hims & Hers Health Inc

HIMS
Add to Watchlist
32.950USD
-0.590-1.76%
Close 06/23, 16:00ETQuotes delayed by 15 min
7.63BMarket Cap
LossP/E TTM

Earnings Forecast

Currency: USD Updated: 2026-06-23
Previous score
6.59
Change
0
The current earnings forecast score of Hims & Hers Health Inc is 6.59, ranking 54 out of 76 in the Healthcare Providers & Services industry. The average price target is 41.00, with a high of 85.00 and a low of 30.00.

Analyst Rating

Based on 17 analysts
Hold
Current Rating
27.509
Target Price
-17.98%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

68
Total
8
Median
9
Average
Company name
Ratings
Analysts
Hims & Hers Health Inc
HIMS
17
CVS Health Corp
CVS
29
Teladoc Health Inc
TDOC
27
HCA Healthcare Inc
HCA
26
Natera Inc
NTRA
23
Tenet Healthcare Corp
THC
23
1
2
3
...
14

Support & Resistance

Relevant data have not been disclosed by the company yet.

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Forecast
Actual

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

FAQs

What is Hims & Hers Health Inc's expected revenue for the next quarter?

Hims & Hers Health Inc's expected revenue is 691.65M.

What is Hims & Hers Health Inc's price target?

Analysts forecast that Hims & Hers Health Inc's price target is USD 41.00, with the highest forecast at USD 85.00 and the lowest forecast at USD 30.00.

How have Hims & Hers Health IncHIMS's recent earnings per share performed?

The market expectation was USD -0.40, while Hims & Hers Health IncHIMS's earnings per share (EPS) for the previous quarter was USD 0.09. EPS for the next quarter is expected at USD 0.04.

What is the analyst rating for Hims & Hers Health Inc?

Based on the ratings of Hims & Hers Health Inc's stock from 17 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.
KeyAI